|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00455 TIANDA PHARMA
Nominal 
0.105 +0.002 (+1.942%) | 2026/06 - Interim HKD(K$) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 14,036 | (9,698) | (49,757) | 76,428 |
| Net Cash from / (used in) Investing Activities | -- | (20,142) | (31,775) | (69,101) | (9,608) |
| Net Cash from / (used in) Financing Activities | -- | (15,161) | (30,649) | (57,394) | (28,890) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (21,267) | (72,122) | (176,252) | 37,930 |
| Cash & Cash Equivalents at beginning of period | -- | 85,688 | 162,442 | 340,277 | 334,002 |
| Effect of Foreign Exchange Rate Changes | -- | 387 | (4,632) | (1,583) | (31,655) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 64,808 | 85,688 | 162,442 | 340,277 |
| Remarks: | Real time quote last updated: 11/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -32,250 |
| %Change | -2.970% |
| EPS / (LPS) | HKD -0.015 |
| NBV Per Share ($) | HKD 0.205 |